A recent study showed that ginkgolide C might promote intestinal barrier function and exert anti-inflammatory effects by inhibiting the nuclear factor kappa-light-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in a dextran sulfate sodium-induced colitis model (36). Here, NFKB1 is linked to colitis.